D-0247-2026 Class III Ongoing
FDA drug recall D-0247-2026 was initiated by Zydus Pharmaceuticals (USA) Inc on Dec 19, 2025 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface. The recall status is ongoing. Affected quantity: 2,136 1000-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 7, 2026
- Initiation Date
- Dec 19, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,136 1000-count bottles
Product description
traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10
Reason for recall
Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
Distribution pattern
Nationwide in the USA
Code information
Lot # EA00237A, Exp Date: 04/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0247-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026